LORD, ABBETT & CO. LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAD0. A total of 7 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
LORD, ABBETT & CO. LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$12,860,000
+15.0%
3,512,000
-13.5%
0.04%
+9.1%
Q2 2018$11,187,000
+234.4%
4,059,000
+103.0%
0.03%
+230.0%
Q2 2016$3,345,0002,000,0000.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 8,100,000$11,854,0002.24%
Mint Tower Capital Management B.V. 4,500,000$6,587,0002.04%
Myriad Asset Management Ltd. 17,000,000$24,926,0001.58%
CQS Cayman LP 12,000,000$17,562,0001.48%
BASSO CAPITAL MANAGEMENT, L.P. 6,400,000$9,344,0001.38%
LINDEN ADVISORS LP 19,855,000$29,087,0001.33%
Opera Trading Capital 3,700,000$5,377,0001.13%
CAMDEN ASSET MANAGEMENT L P /CA 22,575,000$32,945,0001.00%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 25,000,000$36,611,0000.58%
Verition Fund Management LLC 3,200,000$4,686,0000.50%
View complete list of LIGAND PHARMACEUTICALS INC shareholders